Literature DB >> 14668633

Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.

Andrew R Crow1, Alan H Lazarus.   

Abstract

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by autoantibody-mediated platelet destruction. Platelets with associated IgG are targeted for destruction by phagocytic cells bearing Fc receptors in the reticuloendothelial system. While there are a variety of therapeutics available for this incompletely understood disease, one of the treatments of choice is infusion of intravenous immunoglobulin (IVIG). This review will discuss the pathophysiology of ITP with an emphasis on the role of Fcgamma receptors in both the pathogenesis and treatment of the disease by IVIG. Other prominent theories of the mechanisms of action of IVIG, including the role of anti-idiotype antibodies, will also be addressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668633     DOI: 10.1097/00043426-200312001-00004

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  14 in total

Review 1.  Novel clearance mechanisms of platelets.

Authors:  Renata Grozovsky; Karin M Hoffmeister; Hervé Falet
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 2.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

Review 3.  Childhood immune thrombocytopenia: Clinical presentation and management.

Authors:  Mohamed El Faki Osman
Journal:  Sudan J Paediatr       Date:  2012

4.  Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals.

Authors:  Zhong Wu; Jin Zhou; Pankaj Prsoon; Xiaoxia Wei; Xiaojing Liu; Bing Peng
Journal:  Int J Hematol       Date:  2012-10-10       Impact factor: 2.490

Review 5.  The Extensive Regulation of MicroRNA in Immune Thrombocytopenia.

Authors:  Yuerong Zhao; Siyuan Cui; Yan Wang; Ruirong Xu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

6.  Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.

Authors:  Atsuko Asahi; Tetsuya Nishimoto; Yuka Okazaki; Hidekazu Suzuki; Tatsuhiro Masaoka; Yutaka Kawakami; Yasuo Ikeda; Masataka Kuwana
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

7.  Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors.

Authors:  Sietse Q Nagelkerke; Christine W Bruggeman; Joke M M den Haan; Erik P J Mul; Timo K van den Berg; Robin van Bruggen; Taco W Kuijpers
Journal:  Blood Adv       Date:  2018-04-24

8.  Heterozygous mutation SLFN14 K208N in mice mediates species-specific differences in platelet and erythroid lineage commitment.

Authors:  Rachel J Stapley; Christopher W Smith; Elizabeth J Haining; Andrea Bacon; Sian Lax; Vera P Pisareva; Andrey V Pisarev; Steve P Watson; Abdullah O Khan; Neil V Morgan
Journal:  Blood Adv       Date:  2021-01-26

Review 9.  Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?

Authors:  Sietse Q Nagelkerke; Taco W Kuijpers
Journal:  Front Immunol       Date:  2015-01-21       Impact factor: 7.561

Review 10.  Advances in Diagnosis and Treatments for Immune Thrombocytopenia.

Authors:  Shosaku Nomura
Journal:  Clin Med Insights Blood Disord       Date:  2016-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.